Role of Insulin-Like Growth Factor-Binding Protein 5 (IGFBP5) in Organismal and Pancreatic β-Cell Growth

Molecular Endocrinology

Volumn 24, Issue 1, 2010, Pages 178-192

  Gleason, Catherine E ^a   Ning, Yun ^c   Cominski, Tara P ^c   Gupta, Rana ^b   Kaestner, Klaus H ^b   Pintar, John E ^c   Birnbaum, Morris J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Institute for Diabetes   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 5;

APOPTOSIS; ARTICLE; CELL COUNT; CELL GROWTH; CELL SIZE; DIET; GENE ACTIVATION; GENE INDUCTION; GLUCOSE INTOLERANCE; IN VIVO STUDY; METABOLISM; MOUSE; MOUSE STRAIN; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA PROCESSING; WILD TYPE;

ADIPOSITY; ANIMALS; BODY SIZE; CELL LINE; CELL SIZE; EMBRYONIC STEM CELLS; FEMALE; GENE EXPRESSION PROFILING; GLUCOSE INTOLERANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MICE; MICE, TRANSGENIC; ORGAN SIZE; ORGAN SPECIFICITY; PREGNANCY; PROTO-ONCOGENE PROTEINS C-AKT; TIME FACTORS; UP-REGULATION;

MUS;

EID: 73549091003     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0167     Document Type: Article

References (56)

1. Lingohr MK, Buettner R, Rhodes CJ 2002 Pancreatic β-cell growth and survival: a role in obesity-linked type 2 diabetes? Trends Mol Med 8:375-384
2. Kulkarni RN, Brüning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR 1999 Tissue-specific knockout of the insulin receptor in pancreatic β-cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-339
3. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR 2002 β-Cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass. Nat Genet 31:111-115
4. Ueki K, Okada T, Hu J, Liew CW, Assmann A, Dahlgren GM, Peters JL, Shackman JG, Zhang M, Artner I, Satin LS, Stein R, Holzenberger M, Kennedy RT, Kahn CR, Kulkarni RN 2006 Total insulin and IGF-I resistance in pancreatic β-cells causes overt diabetes. Nat Genet 38:583-588
5. Prentki M, Nolan CJ 2006 Islet β-cell failure in type 2 diabetes. J Clin Invest 116:1802-1812
6. Taniguchi CM, Emanuelli B, Kahn CR 2006 Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85-96
7. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA 2001 Islet β-cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 108:1631-1638
8. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, Polonsky KS, Naji A, Birnbaum MJ 2001 Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nat Med 7:1133-1137
9. Manning BD, Cantley LC 2007 AKT/PKB signaling: navigating downstream. Cell 129:1261-1274
10. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM 2002 PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8:1153-1160
11. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC 2001 Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 3:245-252
12. Medema RH, Kops GJ, Bos JL, Burgering BM 2000 AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:782-787
13. Kushner JA, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, Sicinski P, White MF 2005 Cyclins D2 and D1 are essential for postnatal pancreatic β-cell growth. Mol Cell Biol 25:3752-3762
14. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M 1999 Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nat Genet 22:44-52
15. Fatrai S, Elghazi L, Balcazar N, Cras-Méneur C, Krits I, Kiyokawa H, Bernal-Mizrachi E 2006 Akt induces β-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 55:318-325
16. Elghazi L, Balcazar N, Bernal-Mizrachi E 2006 Emerging role of protein kinase B/Akt signaling in pancreatic β-cell mass and function. Int J Biochem Cell Biol 38:157-163
17. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs 3rd WH, Wright CV, White MF, Arden KC, Accili D 2002 The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β-cell growth. J Clin Invest 110:1839-1847
18. Sorenson RL, Brelje TC 1997 Adaptation of islets of Langerhans to pregnancy: β-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301-307
19. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
20. Duan C, Hawes SB, Prevette T, Clemmons DR 1996 Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J Biol Chem 271:4280-4288
21. Duan C, Liimatta MB, Bottum OL 1999 Insulin-like growth factor (IGF)-I regulates IGF-binding protein-5 gene expression through the phosphatidylinositol 3-kinase, protein kinase B/Akt, and p70 S6 kinase signaling pathway. J Biol Chem 274:37147-37153
22. Duan C, Xu Q 2005 Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol 142: 44-52
23. Schneider MR, Wolf E, Hoeflich A, Lahm H 2002 IGF-binding protein-5: flexible player in the IGF system and effector on its own. J Endocrinol 172:423-440
24. Ning Y, Hoang B, Schuller AG, Cominski TP, Hsu MS, Wood TL, Pintar JE 2007 Delayed mammary gland involution in mice with mutation of the insulin-like growth factor binding protein 5 gene. Endocrinology 148:2138-2147
25. Swenne I 1992 Pancreatic β-cell growth and diabetes mellitus. Diabetologia 35:193-201
26. Hügl SR, White MF, Rhodes CJ 1998 Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J Biol Chem 273:17771-17779
27. George M, Ayuso E, Casellas A, Costa C, Devedjian JC, Bosch F 2002 β-Cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest 109:1153-1163
28. Smith FE, Rosen KM, Villa-Komaroff L, Weir GC, Bonner-Weir S 1991 Enhanced insulin-like growth factor I gene expression in re-generating rat pancreas. Proc Natl Acad Sci USA 88:6152-6156
29. Devedjian JC, George M, Casellas A, Pujol A, Visa J, Pelegrín M, Gros L, Bosch F 2000 Transgenic mice overexpressing insulin-like growth factor-II in β-cells develop type 2 diabetes. J Clin Invest 105:731-740
30. Yin P, Xu Q, Duan C 2004 Paradoxical actions of endogenous and exogenous insulin-like growth factor-binding protein-5 revealed by RNA interference analysis. J Biol Chem 279:32660-32666
31. Anisimov SV, Tarasov KV, Riordon D, Wobus AM, Boheler KR 2002 SAGE identification of differentiation responsive genes in P19 embryonic cells induced to form cardiomyocytes in vitro. Mech Dev 117:25-74
32. Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S 2001 Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 107:73-81
33. Johnson SK, Dennis RA, Barone GW, Lamps LW, Haun RS 2006 Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray. Mol Carcinog 45:814-827
34. Miyake H, Nelson C, Rennie PS, Gleave ME 2000 Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway. Endocrinology 141:2257-2265
35. Sheikh MS, Shao ZM, Hussain A, Clemmons DR, Chen JC, Roberts Jr CT, LeRoith D, Fontana JA 1993 Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. J Cell Physiol 155:556-567
36. Stolf BS, Carvalho AF, Martins WK, Runza FB, Brun M, Hirata Jr R, Jordão Neves E, Soares FA, Postigo-Dias J, Kowalski LP, Reis LF 2003 Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas. Cancer Lett 191:193-202
37. Kiepe D, Ciarmatori S, Hoeflich A, Wolf E, Tönshoff B 2005 Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways. Endocrinology 146:3096-3104
38. Cook SA, Matsui T, Li L, Rosenzweig A 2002 Transcriptional effects of chronic Akt activation in the heart. J Biol Chem 277: 22528-22533
39. Schiekofer S, Shiojima I, Sato K, Galasso G, Oshima Y, Walsh K 2006 Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure. Physiol Genomics 27:156-170
40. Hill DJ, Hogg J, Petrik J, Arany E, Han VK 1999 Cellular distribution and ontogeny of insulin-like growth factors (IGFs) and IGF binding protein messenger RNAs and peptides in developing rat pancreas. J Endocrinol 160:305-317
41. Gu G, Wells JM, Dombkowski D, Preffer F, Aronow B, Melton DA 2004 Global expression analysis of gene regulatory pathways during endocrine pancreatic development. Development 131:165-179
42. Salih DA, Tripathi G, Holding C, Szestak TA, Gonzalez MI, Carter EJ, Cobb LJ, Eisemann JE, Pell JM 2004 Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc Natl Acad Sci USA 101: 4314-4319
43. Ning Y, Schuller AG, Bradshaw S, Rotwein P, Ludwig T, Frystyk J, Pintar JE 2006 Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5. Mol Endocrinol 20: 2173-2186
44. Wang J, Zhou J, Powell-Braxton L, Bondy C 1999 Effects of Igf1 gene deletion on postnatal growth patterns. Endocrinology 140: 3391-3394
45. Fernández AM, Kim JK, Yakar S, Dupont J, Hernandez-Sanchez C, Castle AL, Filmore J, Shulman GI, Le Roith D 2001 Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Dev 15:1926-1934
46. Sjögren K, Wallenius K, Liu JL, Bohlooly-Y M, Pacini G, Svensson L, Törnell J, Isaksson OG, Ahrén B, Jansson JO, Ohlsson C 2001 Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 50:1539-1545
47. Di Cola G, Cool MH, Accili D 1997 Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J Clin Invest 99:2538-2544
48. Rajkumar K, Krsek M, Dheen ST, Murphy LJ 1996 Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Invest 98:1818-1825
49. Silha JV, Gui Y, Murphy LJ 2002 Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice. Am J Physiol Endocrinol Metab 283:E937-E945
50. Scharp DW, Kemp CB, Knight MJ, Ballinger WF, Lacy PE 1973 The use of ficoll in the preparation of viable islets of langerhans from the rat pancreas. Transplantation 16:686-689
51. Gupta RK, Gao N, Gorski RK, White P, Hardy OT, Rafiq K, Brestelli JE, Chen G, Stoeckert Jr CJ, Kaestner KH 2007 Expansion of adult β-cell mass in response to increased metabolic demand is dependent on HNF-4α. Genes Dev 21:756-769
52. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP 2002 Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30:e15
53. Tusher VG, Tibshirani R, Chu G 2001 Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121
54. Lawrence JT, Birnbaum MJ 2001 ADP-ribosylation factor 6 delineates separate pathways used by endothelin 1 and insulin for stimulating glucose uptake in 3T3-L1 adipocytes. Mol Cell Biol 21: 5276-5285
55. Bae SS, Cho H, Mu J, Birnbaum MJ 2003 Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J Biol Chem 278:49530-49536
56. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K 2000 Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101:660-667